NICHOLE STANLEY: Open Payments
NPI 1154976595 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,359 in 187 payments from 22 companies in 2025. Trend: 2023 $2,300 · 2024 $4,386 · 2025 $7,359
Food & beverage: $4,670Travel & lodging: $1,429Consulting: $1,260
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 22 | $2,136 |
| GENZYME CORPORATION | 12 | $1,915 |
| GlaxoSmithKline, LLC. | 30 | $603 |
| AstraZeneca Pharmaceuticals LP | 28 | $580 |
| Regeneron Healthcare Solutions, Inc. | 9 | $337 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $265 |
| United Therapeutics Corporation | 10 | $241 |
| Viatris Specialty LLC | 6 | $186 |
| Actelion Pharmaceuticals US, Inc. | 11 | $173 |
| Verona Pharma, Inc. | 8 | $142 |
Products named: INSPIRE, DUPIXENT, NUCALA, GLASSIA, TEZSPIRE, Tyvaso, TRELEGY ELLIPTA, YUPELRI.
Industry payments across FL — which companies pay providers there.
